Last reviewed · How we verify

NCT04657796

Role of High Flow Nasal Oxygen as a Strategy for Weaning From Invasive Mechan

Status unknown Last updated 8 December 2020
What this trial tests

trial testing High Flow Nasal Cannula in Respiratory Failure With Hypoxia in 84 participants. Status unknown.

Timeline
5 December 2020
Primary endpoint
5 October 2022
4 December 2023

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment84
Start date5 December 2020
Primary completion5 October 2022
Estimated completion4 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 100, any sex, with Respiratory Failure With Hypoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

evaluate the Efficacy of high flow nasal oxygen as a weaning strategy in mechanically ventilated patients with respiratory failure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of High Flow Nasal Cannula

Trials testing the same drug.

Other recruiting trials for Respiratory Failure With Hypoxia

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04657796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing